Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 million

A division of French advertising company Publicis Groupe SA (PUBP.PA), and drug company Hikma Pharmaceuticals (HIK.L), have reached separate settlements worth a collective $500 million to resolve claims that they helped fuel the deadly U.S. opioid epidemic.